TY - JOUR
T1 - Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction
AU - Child, Nicholas
AU - Suna, Gonca
AU - Dabir, Darius
AU - Yap, May-lin
AU - Rogers, Toby
AU - Kathirgamanathan, Misha
AU - Arroyo-ucar, Eduardo
AU - Hinojar, Rocio
AU - Mahmoud, Islam
AU - Young, Christopher
AU - Wendler, Olaf
AU - Mayr, Manuel
AU - Sandhu, Banher
AU - Morton, Geraint
AU - Muhly-reinholz, Marion
AU - Dimmeler, Stefanie
AU - Nagel, Eike
AU - Puntmann, Valentina O
PY - 2018/7
Y1 - 2018/7
N2 - Aims
To determine the bioequivalence of several T1 mapping sequences in myocardial characterization of diffuse myocardial fibrosis.
Methods and results
We performed an intra-individual sequence comparison of three types of T1 mapping sequences [MOdified Look-Locker Inversion recovery (MOLLI), Shortened MOdified Look-Locker Inversion recovery ((sh)MOLLI), and SAturation recovery single-SHot Acquisition (SASHA)]. We employed two model diseases of diffuse interstitial fibrosis [patients with non-ischaemic dilated cardiomyopathy (NIDCM), n = 32] and aortic stenosis [(AS), n = 25)]. Twenty-six healthy individuals served as controls. Relationship with collagen volume fraction (CVF) was assessed using endomyocardial biopsies (EMB) intraoperatively in 12 AS patients. T2 mapping (GraSE) was also performed. Myocardial native T1 with MOLLI and shMOLLI showed, firstly, an excellent discriminatory accuracy between health and disease [area under the curves (P-value): 0.94 (0.88–0.99); 0.87 (0.79–0.94); 0.61 (0.49–0.72)], secondly, relationship between histological CVF [native T1 MOLLI vs. shMOLLI vs. SASHA: r = 0.582 (P = 0.027), r = 0.524 (P = 0.046), r = 0.443 (P = 0.150)], and thirdly, with native T2 [r = 0.628(P < 0.001), r = 0.459 (P = 0.003), r = 0.211 (P = 0.083)]. The respective relationships for extracellular volume fraction with CVF [r = 0.489 (P = 0.044), r = 0.417 (0.071), r = 0.353 (P = 0.287)] were significant for MOLLI, but not other sequences. In AS patients, native T2 was significantly higher compared to controls, and associated with levels of C-reactive protein and troponin.
Conclusion
T1 mapping sequences differ in their bioequivalence for discrimination between health and disease as well as associations with diffuse myocardial fibrosis.
AB - Aims
To determine the bioequivalence of several T1 mapping sequences in myocardial characterization of diffuse myocardial fibrosis.
Methods and results
We performed an intra-individual sequence comparison of three types of T1 mapping sequences [MOdified Look-Locker Inversion recovery (MOLLI), Shortened MOdified Look-Locker Inversion recovery ((sh)MOLLI), and SAturation recovery single-SHot Acquisition (SASHA)]. We employed two model diseases of diffuse interstitial fibrosis [patients with non-ischaemic dilated cardiomyopathy (NIDCM), n = 32] and aortic stenosis [(AS), n = 25)]. Twenty-six healthy individuals served as controls. Relationship with collagen volume fraction (CVF) was assessed using endomyocardial biopsies (EMB) intraoperatively in 12 AS patients. T2 mapping (GraSE) was also performed. Myocardial native T1 with MOLLI and shMOLLI showed, firstly, an excellent discriminatory accuracy between health and disease [area under the curves (P-value): 0.94 (0.88–0.99); 0.87 (0.79–0.94); 0.61 (0.49–0.72)], secondly, relationship between histological CVF [native T1 MOLLI vs. shMOLLI vs. SASHA: r = 0.582 (P = 0.027), r = 0.524 (P = 0.046), r = 0.443 (P = 0.150)], and thirdly, with native T2 [r = 0.628(P < 0.001), r = 0.459 (P = 0.003), r = 0.211 (P = 0.083)]. The respective relationships for extracellular volume fraction with CVF [r = 0.489 (P = 0.044), r = 0.417 (0.071), r = 0.353 (P = 0.287)] were significant for MOLLI, but not other sequences. In AS patients, native T2 was significantly higher compared to controls, and associated with levels of C-reactive protein and troponin.
Conclusion
T1 mapping sequences differ in their bioequivalence for discrimination between health and disease as well as associations with diffuse myocardial fibrosis.
UR - http://www.scopus.com/inward/record.url?scp=85051003325&partnerID=8YFLogxK
U2 - 10.1093/ehjci/jex309
DO - 10.1093/ehjci/jex309
M3 - Article
SN - 2047-2404
VL - 19
SP - 768
EP - 776
JO - European Heart Journal-Cardiovascular Imaging
JF - European Heart Journal-Cardiovascular Imaging
IS - 7
ER -